Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Overviews: 9 Aspects of this Diagnoses
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Possible Special Education
      • Possible Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • First Pages of Diagnoses from the Diagnostic and Statistical Manual and the Codes from the ICD-10 for Diagnosis and Compensation
  • Medical & Educational Downloads
  • Contact Us
Select Page

Answer to the Letter to the Editor of S.T. Hassan, et al. concerning “Anxiety and depression 1-year after spinal tumor surgery: a retrospective analysis of psychological and clinical predictors” by R.Z. Ahmed, et al. (Eur Spine J [2025]; doi: 10.1007/s00586-025-09325-7)

by jlohrconsulting | Oct 9, 2025 | Uncategorized

Eur Spine J. 2025 Oct 9. doi: 10.1007/s00586-025-09438-z. Online ahead of print. NO ABSTRACT PMID:41065787 | DOI:10.1007/s00586-025-09438-z

Comparative Study on the Neuroprotective Effects of Perindopril and Benazepril in Experimentally-induced Chronic Mild Stress in Rats

by jlohrconsulting | Oct 9, 2025 | Uncategorized

J Neuroimmune Pharmacol. 2025 Oct 9;20(1):84. doi: 10.1007/s11481-025-10244-z. ABSTRACT Depression remains a major global health issue, characterized by inadequate response rates to conventional antidepressant therapies. This highlights a critical need for novel...

Alterations in serum nudifloramide associated with response to diverse pharmacological treatments in major depressive disorder: a preliminary study

by jlohrconsulting | Oct 9, 2025 | Uncategorized

Metab Brain Dis. 2025 Oct 9;40(7):284. doi: 10.1007/s11011-025-01717-4. ABSTRACT Pharmacological treatments for major depressive disorder (MDD) have limited efficacy, underscoring the need for biomarkers to assess treatment response. Metabolomics enables...

Cognitive Function and Proteomic Changes in Patients with Autoantibody-Positive Neurodegenerative Dementia

by jlohrconsulting | Oct 9, 2025 | Uncategorized

Neurol Ther. 2025 Oct 9. doi: 10.1007/s40120-025-00828-5. Online ahead of print. ABSTRACT INTRODUCTION: Neurodegenerative dementia (ND) is characterized by progressive cognitive decline. The role of autoantibodies in ND remains controversial, as they may contribute to...

Correction: Temporal Predictions from Anhedonia To Anxiety in Adolescents with Major Depressive Disorder

by jlohrconsulting | Oct 9, 2025 | Uncategorized

Res Child Adolesc Psychopathol. 2025 Oct 9. doi: 10.1007/s10802-025-01384-0. Online ahead of print. NO ABSTRACT PMID:41065994 | DOI:10.1007/s10802-025-01384-0
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments